Published in Gene Therapy Weekly, October 8th, 2009
"Indeed whereas TGF-beta suppressed NF-kappa B activity in normal mammary epithelial cells, those engineered to overexpress xIAP demonstrated activation of NF-kappa B when stimulated with TGF-beta. Additionally up-regulated xIAP...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.